Stock listing

NYSE American:MAIA MAIA Biotechnology, Inc. Stock

Home listing (NYSE American) of MAIA Biotechnology, Inc.

Follow MAIA Biotechnology, Inc. into a list and get an email when it puts out news.

Share price · AMEX:MAIA

$1.12 USD +0.05 (+4.7%)

Close on Oct 20, 2026

Past 3 months -23.3% · daily closes, Jul 6, 2026 – Oct 20, 2026, adjusted for splits
Day range
$1.07 – $1.13 USDOct 20, 2026
Volume
184,478 sharesOct 20, 2026
Market cap
$69.15M USDAt the close on Oct 20, 2026 · price × 61.74M shares outstanding
MAIA Biotechnology, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE American:MAIA · Home$1.12 USD+0.05 (+4.7%)184,478$1.08$1.13$1.07$1.07Close on Oct 20, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 20, 2026 · AMEX:MAIA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.12+0.05+4.7%$1.08$1.13$1.07184,478
$1.07-0.03-2.7%$1.09$1.10$1.06799,127
$1.10-0.02-1.8%$1.13$1.15$1.08363,514
$1.120.000.0%$1.10$1.15$1.10295,385
$1.12-0.04-3.4%$1.15$1.16$1.10628,688
$1.16-0.02-1.7%$1.18$1.18$1.15277,456
$1.18-0.04-3.3%$1.22$1.22$1.16229,948
$1.22+0.07+6.1%$1.16$1.24$1.16375,298
$1.15-0.03-2.5%$1.15$1.16$1.13677,144
$1.18-0.01-0.8%$1.17$1.22$1.16359,676
$1.19+0.01+0.8%$1.20$1.21$1.175227,156
$1.18-0.01-0.8%$1.17$1.21$1.17531,014
$1.19+0.02+1.7%$1.19$1.21$1.17405,026
$1.17-0.01-0.8%$1.18$1.22$1.15781,506
$1.18+0.03+2.6%$1.17$1.19$1.15691,458
$1.15-0.03-2.5%$1.20$1.215$1.15677,550
$1.18-0.02-1.7%$1.23$1.265$1.181,011,106
$1.20-0.05-4.0%$1.27$1.33$1.20920,683
$1.25-0.07-5.3%$1.31$1.33$1.25594,997
$1.32-0.05-3.6%$1.35$1.36$1.30627,034
$1.37+0.04+3.0%$1.33$1.37$1.31940,373
$1.33+0.02+1.5%$1.35$1.38$1.301,142,693
$1.31-0.09-6.4%$1.37$1.398$1.31468,257
$1.400.000.0%$1.44$1.45$1.36649,196
$1.40+0.06+4.5%$1.35$1.42$1.34907,382
$1.34-0.05-3.6%$1.42$1.46$1.331,186,176
$1.39+0.09+6.9%$1.30$1.40$1.30800,151
$1.30-0.01-0.8%$1.32$1.32$1.27682,402
$1.31-0.02-1.5%$1.36$1.36$1.30333,193
$1.33+0.02+1.5%$1.33$1.38$1.325553,903
$1.31-0.01-0.8%$1.32$1.348$1.30226,662
$1.32-0.01-0.8%$1.35$1.35$1.30243,248
$1.33-0.04-2.9%$1.38$1.40$1.31470,785
$1.37+0.07+5.4%$1.40$1.46$1.355865,839
$1.30-0.01-0.8%$1.30$1.32$1.28331,349
$1.31-0.02-1.5%$1.33$1.33$1.295258,682
$1.33-0.05-3.6%$1.38$1.38$1.32361,316
$1.38-0.01-0.7%$1.40$1.40$1.37263,099
$1.39-0.02-1.4%$1.41$1.471$1.385558,009
$1.41+0.06+4.4%$1.40$1.46$1.36943,165
$1.35-0.04-2.9%$1.40$1.40$1.325227,998
$1.39+0.01+0.7%$1.38$1.405$1.35379,842
$1.38-0.01-0.7%$1.37$1.40$1.36223,259
$1.39+0.02+1.5%$1.40$1.42$1.38337,165
$1.37-0.02-1.4%$1.39$1.40$1.36235,781
$1.39-0.01-0.7%$1.40$1.40$1.35266,978
$1.40+0.06+4.5%$1.34$1.40$1.34569,026
$1.34-0.04-2.9%$1.36$1.385$1.34179,087
$1.380.000.0%$1.35$1.39$1.335179,640
$1.38-0.03-2.1%$1.40$1.41$1.36276,270
$1.41-0.01-0.7%$1.38$1.41$1.38202,835
$1.420.000.0%$1.42$1.44$1.39333,250
$1.42+0.02+1.4%$1.47$1.47$1.38347,413
$1.40+0.04+2.9%$1.38$1.41$1.36276,099
$1.36+0.04+3.0%$1.32$1.38$1.31384,213
$1.32+0.07+5.6%$1.25$1.32$1.23650,171
$1.250.000.0%$1.25$1.27$1.21231,913
$1.25+0.05+4.2%$1.22$1.27$1.19290,595
$1.20-0.04-3.2%$1.25$1.26$1.19505,197
$1.24-0.04-3.1%$1.27$1.31$1.22520,947
$1.28+0.04+3.2%$1.29$1.315$1.26359,590
$1.24-0.04-3.1%$1.28$1.30$1.24404,718
$1.28-0.02-1.5%$1.28$1.299$1.26446,667
$1.30-0.03-2.3%$1.30$1.32$1.275328,533
$1.33+0.05+3.9%$1.30$1.35$1.281360,367
$1.28-0.02-1.5%$1.33$1.33$1.27506,740
Ticker
NYSE American:MAIA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NYSE American
Currency
USD

What changed lately

Latest news

MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial

Sep 16, 2026

Closed $1.40 (+4.5%) on Sep 16, 2026

MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO

Sep 15, 2026

Closed $1.34 (-3.6%) on Sep 15, 2026

MAIA Biotechnology Delivers Oral and Poster Presentations Showcasing Next-Generation Telomere-Targeting Cancer Therapies at IRT 2026

Sep 10, 2026

Closed $1.31 (-1.5%) on Sep 10, 2026

MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial

Jul 8, 2026

Closed $1.47 (0.0%) on Jul 8, 2026

MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer

Jun 25, 2026

MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University

Jun 18, 2026

MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial

Jun 4, 2026

MAIA Biotechnology Receives FDA Clearance to Open U.S. Enrollment in Ongoing Phase 2 THIO-101 Trial Expansion

Jun 3, 2026

MAIA Biotechnology Announces Open Market Purchases by CEO and Director

Jun 2, 2026

MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology

Jun 1, 2026

All MAIA Biotechnology, Inc. news

Decks

MAIA Biotechnology, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
26 in the last 12 months · 47 in all · newest Sep 16, 2026 · oldest 2025
Decks
22 decks · latest Oct 6, 2026

Where MAIA Biotechnology, Inc. is listed

ListingExchangeCountryCurrency
NYSE American:MAIA · Home listing · This pageNYSE AmericanUnited StatesUSD
BOATS:MAIABOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about MAIA Biotechnology, Inc.